Evidence map›Paper›PMID 28416808›Full record

ArticleMolecular psychiatry2018

Ptchd1 deficiency induces excitatory synaptic and cognitive dysfunctions in mouse.

D C Ung, G Iacono, H Méziane, E Blanchard, M-A Papon, M Selten, J-R van Rhijn, R Montjean, J Rucci, S Martin and 16 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 6 institutions in 3 countries.

D C UngUniversity François-Rabelais, UMR Imaging and Brain, Tours, France.
G IaconoDepartment of Molecular Biology, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, The Netherlands.
H MézianeCELPHEDIA PHENOMIN, Institut Clinique de la Souris (ICS), CNRS, INSERM, University of Strasbourg, Illkirch-Graffenstaden, France.
E BlanchardUniversity François-Rabelais, UMR Imaging and Brain, Tours, France.
M-A PaponUniversity François-Rabelais, UMR Imaging and Brain, Tours, France.
M SeltenDepartment of Cognitive Neuroscience, Department of Human Genetics, Radboudumc, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.
J-R van RhijnDepartment of Cognitive Neuroscience, Department of Human Genetics, Radboudumc, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.
R MontjeanInstitut Cochin, 24 rue du Fg St Jacques, Paris, France.
J RucciInstitut Cochin, 24 rue du Fg St Jacques, Paris, France.
S MartinUniversité Côte d'Azur, INSERM, CNRS, IPMC, France.ORCID 0000-0001-6771-7645
A FleetDepartment of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
M-C BirlingCELPHEDIA PHENOMIN, Institut Clinique de la Souris (ICS), CNRS, INSERM, University of Strasbourg, Illkirch-Graffenstaden, France.
S MarouillatUniversity François-Rabelais, UMR Imaging and Brain, Tours, France.
R RoepmanDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
M SelloumCELPHEDIA PHENOMIN, Institut Clinique de la Souris (ICS), CNRS, INSERM, University of Strasbourg, Illkirch-Graffenstaden, France.
A LuxCELPHEDIA PHENOMIN, Institut Clinique de la Souris (ICS), CNRS, INSERM, University of Strasbourg, Illkirch-Graffenstaden, France.
R-A ThépaultUniversity François-Rabelais, UMR Imaging and Brain, Tours, France.
P HamelDepartment of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
K MittalMolecular Neuropsychiatry & Development (MiND) Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
J B VincentMolecular Neuropsychiatry & Development (MiND) Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
O DorseuilInstitut Cochin, 24 rue du Fg St Jacques, Paris, France.
H G StunnenbergDepartment of Molecular Biology, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, The Netherlands.
P BilluartInstitut Cochin, 24 rue du Fg St Jacques, Paris, France.
N Nadif KasriDepartment of Cognitive Neuroscience, Department of Human Genetics, Radboudumc, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.
Y HéraultCELPHEDIA PHENOMIN, Institut Clinique de la Souris (ICS), CNRS, INSERM, University of Strasbourg, Illkirch-Graffenstaden, France.
F LaumonnierUniversity François-Rabelais, UMR Imaging and Brain, Tours, France.
Centre National de la Recherche Scientifique · FRRadboud University Nijmegen · NLUniversité de Tours · FRInserm · FRCentre for Addiction and Mental Health · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synapse development and neuronal activity represent fundamental processes for the establishment of cognitive function. Structural organization as well as signalling pathways from receptor stimulation to gene expression regulation are mediated by synaptic activity and misregulated in neurodevelopmental disorders such as autism spectrum disorder (ASD) and intellectual disability (ID). Deleterious mutations in the PTCHD1 (Patched domain containing 1) gene have been described in male patients with X-linked ID and/or ASD. The structure of PTCHD1 protein is similar to the Patched (PTCH1) receptor; however, the cellular mechanisms and pathways associated with PTCHD1 in the developing brain are poorly determined. Here we show that PTCHD1 displays a C-terminal PDZ-binding motif that binds to the postsynaptic proteins PSD95 and SAP102. We also report that PTCHD1 is unable to rescue the canonical sonic hedgehog (SHH) pathway in cells depleted of PTCH1, suggesting that both proteins are involved in distinct cellular signalling pathways. We find that Ptchd1 deficiency in male mice (Ptchd1

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsCognitionCognitive DysfunctionDisks Large Homolog 4 ProteinGuanylate KinasesHippocampusMaleMembrane ProteinsMiceMice, Inbred C57BLNeuronsSignal TransductionSynapsesSynaptic TransmissionBasic Helix-Loop-Helix ProteinsDisks Large Homolog 4 ProteinDlg4 protein, mouseDlgh3 protein, mouseGuanylate KinasesMembrane ProteinsPtchd1 protein, mouse

Identifiers

PMID28416808
PMCPMC5984103
OpenAlexW2606066880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.